Top 10 Companies in the Global N-glycanase Market (2026): Market Leaders Powering Global Biotech

MARKET INSIGHTS

The Global N-glycanase market size was valued at USD 85 million in 2024. The market is projected to grow from USD 89 million in 2025 to USD 125 million by 2032, exhibiting a CAGR of 5.2% during the forecast period.

N-glycanase, also known as PNGase, is a deglycosylating enzyme that cleaves N-linked glycans from glycoproteins. This enzymatic activity plays a critical role in glycoprotein analysis, protein characterization, and biopharmaceutical quality control. The enzyme finds extensive applications in biotechnology research, therapeutic protein development, and diagnostic testing.

The market growth is driven by increasing demand for biopharmaceuticals, rising prevalence of chronic diseases requiring glycoprotein-based therapies, and advancements in glycomics research. Furthermore, the expanding applications of N-glycanase in cancer biomarker discovery and monoclonal antibody production are creating new opportunities. Key players like New England Biolabs, Thermo Fisher Scientific, and Merck KGaA have recently launched high-purity recombinant N-glycanase products to meet the growing research and industrial demands.

Global N-glycanase Market – View in Detailed Research Report

Global N-glycanase Market Size

The Global N-glycanase market is valued at USD 85 million in 2024 and is expected to reach USD 115 million by 2030, reflecting a compound annual growth rate (CAGR) of 5.2% during the forecast period.

What is N-glycanase?

N-glycanase (PNGase) is a specialized enzyme that removes N-linked glycans from glycoproteins, enabling detailed structural analysis and ensuring product consistency in biopharmaceutical manufacturing.

🔟 1. Sunson Industry Group

Headquarters: Shanghai, China
Key Offering: Industrial‑scale recombinant N‑glycanase, GMP‑grade enzymes for research and diagnostics

Sunson has positioned itself as a cost‑effective alternative to Western suppliers, offering high‑purity enzymes tailored for large‑scale biopharma and academic applications.

Sustainability & Growth Initiatives:

• Investing in scalable bioreactor platforms to increase yield
• Partnering with Chinese biotech hubs to support local manufacturing
• Expanding GMP certification to meet global regulatory standards

🔟 2. New England Biolabs

Headquarters: Ipswich, Massachusetts, USA
Key Offering: High‑purity recombinant PNGase F, enzyme kits for glycoprotein analysis

NEB delivers cutting‑edge enzymes with proven activity and specificity, supporting research labs and biopharma companies worldwide.

Sustainability & Growth Initiatives:

• Continuous R&D for engineered variants with enhanced stability
• Digital platform for workflow optimization and data integration
• Commitment to reducing carbon footprint across manufacturing

🔟 3. Promega Corporation

Headquarters: Madison, Wisconsin, USA
Key Offering: Recombinant PNGase enzymes, assay kits for protein characterization

Promega combines robust enzyme performance with user‑friendly kits, facilitating rapid glycan release in proteomic workflows.

Sustainability & Growth Initiatives:

• Investment in green chemistry processes for enzyme production
• Collaborations with academic institutions for glycomics research
• Expansion of global distribution network to emerging markets

🔟 4. Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA
Key Offering: High‑purity PNGase F, integrated workflow solutions for biopharma analytics

Thermo Fisher provides comprehensive platforms that integrate enzyme usage with downstream mass spectrometry and data analysis.

Sustainability & Growth Initiatives:

• Development of AI‑driven workflow optimization tools
• Expansion of GMP‑grade production lines
• Commitment to circular economy principles in reagent manufacturing

🔟 5. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Recombinant PNGase enzymes, enzyme‑based analytical kits

Merck leverages its strong R&D pipeline to deliver enzymes with superior specificity for therapeutic protein analysis.

Sustainability & Growth Initiatives:

• Investment in renewable energy for production facilities
• Partnerships with biopharma companies for process development
• Enhanced quality control protocols for GMP compliance

🔟 6. Roche Diagnostics

Headquarters: Basel, Switzerland
Key Offering: High‑purity PNGase enzymes, diagnostic assay kits

Roche’s diagnostics division integrates N‑glycanase into comprehensive biomarker panels for disease detection.

Sustainability & Growth Initiatives:

• Digital health integration for real‑time data analytics
• Research collaborations on next‑generation diagnostics
• Carbon‑neutral production targets by 2030

🔟 7. Takara Bio Inc.

Headquarters: Shiga, Japan
Key Offering: Recombinant PNGase enzymes, kits for high‑throughput glycan analysis

Takara Bio focuses on scalable production and high‑throughput solutions for the rapidly growing Japanese market.

Sustainability & Growth Initiatives:

• Investment in automated production lines
• Collaborations with Japanese universities for glycomics research
• Eco‑friendly packaging initiatives

🔟 8. QIAGEN N.V.

Headquarters: Hilden, Germany
Key Offering: Recombinant PNGase enzymes, integrated sample preparation kits

QIAGEN delivers user‑friendly kits that streamline sample prep for mass spectrometry and proteomics.

Sustainability & Growth Initiatives:

• Development of low‑water‑usage production processes
• Partnerships with global biopharma companies for process optimization
• Commitment to ISO 14001 environmental standards

🔟 9. Agilent Technologies

Headquarters: Santa Clara, California, USA
Key Offering: Recombinant PNGase enzymes, advanced analytical instrumentation

Agilent integrates its enzymes with cutting‑edge LC‑MS platforms for comprehensive glycoprotein profiling.

Sustainability & Growth Initiatives:

• Investment in AI‑powered data analytics for glycan profiling
• Expansion of global service centers for rapid turnaround
• Reduction of chemical waste through greener reagent formulations

🔟 10. Ludger Ltd

Headquarters: Hamburg, Germany
Key Offering: High‑purity PNGase enzymes, specialized industrial‑grade products

Ludger focuses on robust, industrial‑grade enzymes for large‑scale biopharmaceutical manufacturing.

Sustainability & Growth Initiatives:

• Investment in scalable bioprocessing technologies
• Partnerships with European biopharma firms for process development
• Carbon‑neutral production targets by 2035

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/277765/global-nglycanase-market
Get Full Report Here: https://www.24chemicalresearch.com/reports/277765/global-nglycanase-market

OUTLOOK

Global N‑glycanase market is expected to continue expanding at a CAGR of 5.2% from 2026 to 2034, driven by the rapid growth of biopharmaceuticals, personalized medicine, and advanced glycoprotein analytics.

FUTURE TRENDS

• High‑purity recombinant N‑glycanase products becoming industry standard for biopharma and diagnostics.
• Expansion of applications in cancer biomarker discovery, monoclonal antibody production, and cell‑and‑gene therapies.
• Emerging technologies such as immobilized enzymes, AI‑optimized workflows, and reusable columns reducing cost and increasing throughput.
• Growing focus on sustainability and carbon‑neutral manufacturing across the enzyme supply chain.